Alternate PAX3 and PAX7 C-terminal isoforms in myogenic differentiation and sarcomagenesis

Clinical and Translational Oncology

Volumn 13, Issue 3, 2011, Pages 194-203

  Charytonowicz, Elizabeth ^a   Matushansky, Igor ^b   Castillo Martin, Mireia ^b   Hricik, Todd ^b   Cordon Cardo, Carlos ^b   Ziman, Mel ^a,c  

^a EDITH COWAN UNIVERSITY   (Australia)

^b Och Spine at New York Presbyterian Hospitals   (United States)

^c UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

Alveolar rhabdomyosarcoma; Myogenic differentiation; Pax3 transcripts; PAX3FKHR; Pax7 transcripts; PAX7FKHR

Indexed keywords

ISOPROTEIN; MYOD1 PROTEIN; MYOGENIN; MYOSIN HEAVY CHAIN; TRANSCRIPTION FACTOR FKHR; TRANSCRIPTION FACTOR PAX3; TRANSCRIPTION FACTOR PAX7;

ANIMAL CELL; ARTICLE; CARBOXY TERMINAL SEQUENCE; CARCINOGENESIS; CELL DIFFERENTIATION; CELL LINEAGE; CONTROLLED STUDY; DEVELOPMENTAL GENE; FUSION GENE; GENE; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC TRANSFECTION; MESENCHYMAL STEM CELL; MOUSE; MUSCLE CELL; MUSCLE DEVELOPMENT; MYOD1 GENE; MYOGENIN GENE; MYOSIN HEAVY CHAIN GENE; NONHUMAN; PROTEIN EXPRESSION; PROTEIN FUNCTION; RHABDOMYOSARCOMA; TRANSCRIPTION FACTOR FKHR GENE; TRANSCRIPTION FACTOR PAX3 GENE; TRANSCRIPTION FACTOR PAX7 GENE;

ANIMALS; CELL DIFFERENTIATION; CELL LINE; CELL LINEAGE; HUMANS; IMMUNOHISTOCHEMISTRY; MESENCHYMAL STEM CELLS; MICE; MUSCLE CELLS; PAIRED BOX TRANSCRIPTION FACTORS; PAX7 TRANSCRIPTION FACTOR; PROTEIN ISOFORMS; RECOMBINANT FUSION PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RHABDOMYOSARCOMA, ALVEOLAR; TRANSFECTION;

EID: 79958232040     PISSN: 1699048X     EISSN: 16993055     Source Type: Journal    
DOI: 10.1007/s12094-011-0640-y     Document Type: Article

References (28)

1. Chi N, Epstein JA (2002) Getting your Pax straight: Pax proteins in development and disease. Trends Genet 18:41-47 (Pubitemid 34031857)
2. Mikkola I, Bruun JA, Bjorkoy G et al (1999) Phosphorylation of the transactivation domain of Pax6 by extracellular signal-regulated kinase and p38 mitogen-activated protein kinase. J Biol Chem 274:15115-15126
3. Underhill DA, Gros P (1997) The paired-domain regulates DNA binding by the homeodomain within the intact Pax-3 protein. J Biol Chem 272:14175-14182
4. Lamey TM, Koenders A, Ziman M (2004) Pax genes in myogenesis: alternate transcripts add complexity. Histol Histopathol 19:1289-1300 (Pubitemid 39386787)
5. Vogan KJ, Underhill DA, Gros P (1996) An alternative splicing event in the Pax-3 paired domain identifies the linker region as a key determinant of paired domain DNA-binding activity. Mol Cell Biol 16:6677-6686 (Pubitemid 26389726)
6. Ziman MR, Fletcher S, Kay PH (1997) Alternate Pax7 transcripts are expressed specifically in skeletal muscle, brain and other organs of adult mice. Int J Biochem Cell Biol 29:1029-1036 (Pubitemid 27478889)
7. White RB, Ziman MR (2008) Genome-wide discovery of Pax7 target genes during development. Physiol Genomics 33:41-49 (Pubitemid 351451373)
8. Du S, Lawrence EJ, Strzelecki D et al (2005) Coexpression of alternatively spliced forms of PAX3, PAX7, PAX3-FKHR and PAX7-FKHR with distinct DNA binding and transactivation properties in rhabdomyosarcoma. Int J Cancer 115:85-92 (Pubitemid 40559671)
9. Barr FG, Fitzgerald JC, Ginsberg JP et al (1999) Predominant expression of alternative PAX3 and PAX7 forms in myogenic and neural tumor cell lines. Cancer Res 59:5443-5448 (Pubitemid 29526453)
10. Pritchard C, Grosveld G, Hollenbach AD (2003) Alternative splicing of Pax3 produces a transcriptionally inactive protein. Gene 305:61-69 (Pubitemid 36197866)
11. Parker CJ, Shawcross SG, Li H et al (2004) Expression of PAX 3 alternatively spliced transcripts and identification of two new isoforms in human tumors of neural crest origin. Int J Cancer 108:314-320 (Pubitemid 37541789)
12. Wang Q, Kumar S, Slevin M et al (2006) Functional analysis of alternative isoforms of the transcription factor PAX3 in melanocytes in vitro. Cancer Res 66:8574-8580 (Pubitemid 44449171)
13. Barber TD, Barber MC, Cloutier TE et al (1999) PAX3 gene structure, alternative splicing and evolution. Gene 237:311-319 (Pubitemid 29457640)
14. Yaffe D, Saxel O (1977) A myogenic cell line with altered serum requirements for differentiation. Differentiation 7:159-166 (Pubitemid 8054895)
15. Wakitani S, Saito T, Caplan AI (1995) Myogenic cells derived from rat bone marrow mesenchymal stem cells exposed to 5-azacytidine. Muscle Nerve 18:1417-1426
16. Pittenger M, Vanguri P, Simonetti D et al (2002) Adult mesenchymal stem cells: potential for muscle and tendon regeneration and use in gene therapy. J Musculoskelet Neuronal Interact 2:309-320
17. Charytonowicz E, Cordon-Cardo C, Matushansky I et al (2009) Alveolar rhabdomyosarcoma: is the cell of origin a mesenchymal stem cell? Cancer Lett 279:126-136
18. Gang EJ, Bosnakovski D, Simsek T et al (2008) Pax3 activation promotes the differentiation of mesenchymal stem cells toward the myogenic lineage. Exp Cell Res 314:1721-1733
19. Wannenes F, Caprio M, Gatta L et al (2008) Androgen receptor expression during C2C12 skeletal muscle cell line differentiation. Mol Cell Endocrinol 292:11-19
20. Blake JA, Ziman MR (2005) Pax3 transcripts in melanoblast development. Dev Growth Differ 47:627-635 (Pubitemid 43151678)
21. de Alava E, Ladanyi M, Rosai J et al (1995) Detection of chimeric transcripts in desmoplastic small round cell tumor and related developmental tumors by reverse transcriptase polymerase chain reaction. A specific diagnostic assay. Am J Pathol 147:1584-1591
22. Graf Finckenstein F, Shahbazian V, Davicioni E et al (2008) PAX-FKHR function as pangenes by simultaneously inducing and inhibiting myogenesis. Oncogene 27:2004-2014 (Pubitemid 351442734)
23. Czerny T, Schaffner G, Busslinger M (1993) DNA sequence recognition by Pax proteins: bipartite structure of the paired domain and its binding site. Genes Dev 7:2048-2061 (Pubitemid 23312955)
24. Vogan KJ, Gros P (1997) The C-terminal subdomain makes an important contribution to the DNA binding activity of the Pax-3 paired domain. J Biol Chem 272:28289-28295 (Pubitemid 27517771)
25. Wang Q, Fang WH, Krupinski J et al (2008) Pax genes in embryogenesis and oncogenesis. J Cell Mol Med 12:2281-2294
26. Deneen B, Denny CT (2001) Loss of p16 pathways stabilizes EWS/FLI1 expression and complements EWS/FLI1 mediated transformation. Oncogene 20:6731-6741 (Pubitemid 33020602)
27. Xia SJ, Barr FG (2004) Analysis of the transforming and growth suppressive activities of the PAX3-FKHR oncoprotein. Oncogene 23:6864-6871 (Pubitemid 39279987)
28. Vorobyov E, Horst J (2004) Expression of two protein isoforms of PAX7 is controlled by competing cleavage-polyadenylation and splicing. Gene 342:107-112 (Pubitemid 39457183)